Search results
Cervavac Vaccine is a vaccine used to prevent cervical, vulvar, and vaginal cancers associate with human papillomavirus (HPV) in women. it works by initiating a mild infection to stimulate the body's immune system to produce antibodies to protect against any future infections.
Sep 1, 2022 · NEW DELHI: Cervavac, India's first indigenously developed vaccine for preventing cervical cancer caused by Human Papilloma Virus ( HPV ), is likely to be priced between Rs 200-400 per dose, Serum Institute of India ( SII) CEO Adar Poonawala said on Thursday.
Sep 1, 2022 · India launches its own cervical cancer vaccine, to cost between Rs 200-400. The qHPV vaccine, called CERVAVAC, will be manufactured by the Serum Institute of India (SII) along with the...
Meanwhile, India's first indigenously developed vaccine to prevent cervical cancer, CERVAVAC, is all set to be available later this year, costing between ₹ 200-400 a shot. CERVAVAC will be...
Sep 1, 2022 · The Minister said, the most promising intervention for preventing cervical cancer is vaccination against human papillomavirus (HPV). It is estimated that HPV types 16 and 18 (HPV-16 and HPV-18) together contribute to approximately 70% of all invasive cervical cancer cases worldwide.
Sep 1, 2022 · India's first indigenously developed quadrivalent Human Papilloma Virus (HPV) vaccine for the prevention of cervical cancer will be launched in a few months and made available to the people in an affordable price range of Rs 200-400.
Currently, two HPV vaccines by foreign manufacturers are available in India: the quadrivalent vaccine (Gardasil Merck), priced at ₹ 2,800 per dose; and a bivalent vaccine (Cervarix from ...
The vaccine works by triggering your body's immune system to attack certain HPV types, which have been linked to many cases of cervical cancer. According to experts, it is best to get the vaccine ...
Sep 1, 2022 · India’s first indigenously developed vaccine to prevent cervical cancer, CERVAVAC, will likely cost ₹200-400 a shot and be commercially available later this year, said Adar Poonawalla, CEO,...
Sep 1, 2022 · Ceravac, an indigenously developed vaccine for cervical cancer caused by the human-papillomavirus (HPV), will be priced between Rs 200-400 per dose and available in a few months, said manufacturer Serum Institute of India on Thursday.
